This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Acura Pharmaceuticals Inc (ACUR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 774.00K 12.34M 7.48M 35.68M
Receivables 76.00K 194.00K 43.00K 153.00K
Inventories 304.00K 251.00K 219.00K 0.00
Other Current Assets 66.00K 120.00K 0.00 0.00
Total Current Assets 13.23M 27.45M 27.99M 36.13M
Property, Plant & Equipment, Gross 2.75M 2.62M 2.60M 2.48M
Accumulated Depreciation & Depletion 1.79M 1.68M 1.54M 1.44M
Property, Plant & Equipment, Net 957.00K 941.00K 1.05M 1.04M
Intangibles 1.84M 0.00 0.00 0.00
Other Non-Current Assets 162.00K 236.00K 11.00K 0.00
Total Non-Current Assets 2.96M 1.18M 1.06M 1.04M
Liabilities & Shareholder Equity
Total Assets 16.20M 28.63M 29.05M 37.17M
Accounts Payable 217.00K 274.00K 994.00K 53.00K
Short Term Debt 1.76M 0.00 0.00 0.00
Other Current Liabilities 54.00K 5.00K 37.00K 0.00
Total Current Liabilities 2.99M 1.11M 1.42M 530.00K
Long Term Debt 7.96M 9.60M 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 190.00K 0.00 5.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 8.15M 9.60M 5.00K 0.00
Total Liabilities 11.14M 10.71M 1.42M 530.00K
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 5.05M 17.92M 27.63M 36.64M
Common Par 488.00K 483.00K 459.00K 453.00K
Additional Paid In Capital 366.90M 366.53M 362.42M 361.73M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -362.32M -349.11M -335.21M -325.54M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -13.00K 19.00K -40.00K 0.00
Total Capitalization 13.01M 27.52M 27.63M 36.64M
Total Equity 5.05M 17.92M 27.63M 36.64M
Total Liabilities & Stock Equity 16.20M 28.63M 29.05M 37.17M
Total Common Shares Outstanding 48.85M 48.32M 45.87M 45.32M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 48.89M 47.76M 47.52M 47.50M
Diluted Weighted Shares Outstanding 48.89M 47.76M 47.52M 48.01M
Number of Employees 15 15 15 15
Number of Part-Time Employees 0 0 0 0
ACUR News

ACUR Acura Pharmaceuticals Inc

Analysts Ratings for ACUR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ACUR ANALYST REPORT

Brokerage Partners

ACUR Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs